Crossmark

Clarithromycin prevents preterm birth and neonatal mortality by dampening alarmin-induced maternal–fetal inflammation in mice

Published Online: 2022-06-20

Published Print: 2022-12

Authors

Galaz, Jose

Romero, Roberto

Arenas-Hernandez, Marcia

Farias-Jofre, Marcelo

Motomura, Kenichiro

Liu, Zhenjie

Kawahara, Naoki

Demery-Poulos, Catherine

Liu, Tzu Ning

Padron, Justin

Panaitescu, Bogdan

Gomez-Lopez, Nardhy
Funding

Funding for this research was provided by:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN275201300006C, HHSN275201300006C)

Wayne State University Perinatal Initiative in Maternal, Perinatal and Child Health
License Information

Text and Data Mining valid from 2022-06-20

Version of Record valid from 2022-06-20
More Information

Article History

Received: 22 January 2022

Accepted: 12 May 2022

First Online: 20 June 2022

Declarations

:

: All experiments and procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at Wayne State University (Protocol No. 18–03-0584 and 21–04-3506). The methods are reported in accordance with ARRIVE guidelines for the reporting of animal experiments. All animal experimental protocols have been carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current